Loading…

Mauna Kea Technologies and Tasly Pharmaceutical Group have incorporated a joint venture, Tasly Mauna Kea Medical Engineering Technology Co. Ltd., based in Zhejiang province, China. The JV will commercialize Cellvizio in China and develop a neurosurgical platform worldwide.
“Tasly Mauna Kea Medical Engineering Technology Co. Ltd., based in the Zheijang province of China, is now legally incorporated with registered capital of RMB 250 million.”maunakeatech.com
Summarized from public sources; check the original articles before acting on it.